Suchergebnisse - "Caratozzolo, Salvatore"

PubPharm (8)

1

Onabotulinumtoxin-A : Previous Prophylactic Treatment Might Improve Subsequent Anti-CGRP Monoclonal Antibodies Response in Patients with Chronic Migraine

enthalten in: Toxins | 2023

von Ceccardi, G. | Schiano di Cola, F. | Caratozzolo, S. | +4

2

An observational study on monoclonal antibodies against calcitonin-gene-related peptide and its receptor

enthalten in: European journal of neurology | 2023

von Schiano di Cola, F. | Bolchini, M. | Ceccardi, G. | +4

3

Migraine Disability Improvement during Treatment with Galcanezumab in Patients with Chronic and High Frequency Episodic Migraine

enthalten in: Neurology international | 2023

von di Cola, F. | Bolchini, M. | Caratozzolo, S. | +5

4

Migraine Disability and Severity Improvement during Long-Term Treatment with Erenumab

enthalten in: European neurology | 2023

von Bolchini, M. | Schiano di Cola, F. | Ceccardi, G. | +4

5

CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients

enthalten in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology | 2022

von Schiano di Cola, F. | Caratozzolo, S. | Bolchini, M. | +5

6

CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients

enthalten in: Neurological sciences | 2022

von Schiano di Cola, F. | Caratozzolo, S. | Bolchini, M. | +5

7

CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients

enthalten in: Neurological sciences | 2022

von Schiano di Cola, F. | Caratozzolo, S. | Bolchini, M. | +5

8

Photophobia and migraine outcome during treatment with galcanezumab

enthalten in: Frontiers in neurology | 2022

von Schiano di Cola, F. | Ceccardi, G. | Bolchini, M. | +4

1
[1]